Skip to content
Yakov Pakhomov MD, PhD· @yakov_pakhomov · X·· 12 hours agoScore60
Body

@adamfeuerstein Fair point on the control arm: for macroscopic stage III, neoadjuvant IO is now the bar (NADINA/S1801). But resected IIB/C and microscopic stage III have no neoadjuvant option — that's where INTerpath-001 matters. OS and subgroups will decide. #ESMO26

Heat 0 · 0 likes · 0 replies · 0 reposts

Source: Yakov Pakhomov MD, PhD · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org